AstraZeneca AZN0.60%increase; green up pointing triangle plans to spend GBP650 million ($828.8 million) on vaccine programs and various other initiatives in the U.K. The pharmaceutical company ...

Additionally, we have even greater US investment in manufacturing and R&D planned, leveraging our two large R&D sites in Gaithersburg MD and Cambridge MA. Overall, we are making excellent progress ...

AstraZeneca succeeded in thwarting Pfizer's takeover plans – but was forced to promise investors that it could deliver very rapid growth – forecasting revenues of $45 billion by 2023, compared ...

AstraZeneca is bolstering its US manufacturing ... leveraging our two large R&D sites in Gaithersburg MD and Cambridge MA.’ Soriot also told reporters the drugmaker will maintain its 2025 ...

AstraZeneca has 11 production sites in the U.S. covering small molecules, biologics as well as cell therapy. It also has two large R&D sites in Gaithersburg MD and Cambridge MA.” Guidance ...

The new functional genomics lab is the result of a partnership between Cambridge, AstraZeneca, and the U.K.’s Medical Research Council, and is part of the U.K.’s Human Functional Genomics ...

The Cambridge-based pharmaceutical company behind a variety of medicines paid its chief executive Pascal Soriot £14.7 million in 2024. The chief executive of drugmaker AstraZeneca was handed a pa ...

Pascal Soriot, Chief Executive Officer, AstraZeneca, said ... leveraging our two large R&D sites in Gaithersburg MD and Cambridge MA. Overall, we are making excellent progress toward our ambition ...